You are here

Article info

Article menu

Download PDFPDF

XML
Commentary
Antibiotic therapy and outcome from immune-checkpoint inhibitors

Authors

  • David J. Pinato Department of Surgery and CancerImperial College London, Faculty of Medicine, Hammersmith Hospital Du Cane Road W120NN London UK Imperial College London Hammersmith Campus Du Cane Road W12 0HS London UK PubMed articlesGoogle scholar articles
  • Daria Gramenitskaya Department of Surgery and CancerImperial College London, Faculty of Medicine, Hammersmith Hospital Du Cane Road W120NN London UK PubMed articlesGoogle scholar articles
  • Daniel M. Altmann Department of Immunology and Inflammation, Faculty of MedicineImperial College London W12 0NN London UK PubMed articlesGoogle scholar articles
  • Rosemary J. Boyton Lung Immunology Group, Department of Infectious Disease, Faculty of MedicineImperial College London W12 0NN London UK Department of Respiratory MedicineRoyal Brompton & Harefield NHS Foundation Trust SW3 6NP London UK PubMed articlesGoogle scholar articles
  • Benjamin H. Mullish Department of Surgery and CancerImperial College London, Faculty of Medicine, Hammersmith Hospital Du Cane Road W120NN London UK PubMed articlesGoogle scholar articles
  • Julian R. Marchesi Department of Surgery and CancerImperial College London, Faculty of Medicine, Hammersmith Hospital Du Cane Road W120NN London UK PubMed articlesGoogle scholar articles
  • Mark Bower National Centre for HIV Malignancy, Department of OncologyChelsea & Westminster Hospital Fulham Road SW10 9NH London UK PubMed articlesGoogle scholar articles
  1. ↵a +44 0207 5942799 david.pinato{at}imperial.ac.uk
View Full Text

Citation

Pinato DJ, Gramenitskaya D, Altmann DM, et al
Antibiotic therapy and outcome from immune-checkpoint inhibitors
Journal for ImmunoTherapy of Cancer 2019;7:287. doi: 10.1186/s40425-019-0775-x

Publication history

  • Received July 12, 2019
  • Accepted October 9, 2019
  • First published November 6, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.